Dianna Howard, MD
Transplant Hepatology · Winston Salem, NCNPI 1730109307
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.4%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Johnson & Johnson at 41.0% of the total. Reporting peaked in 2023 at $10,327 and has fallen 69.5% since, to $3,149 in 2025.
Across 51 payments — averaging $352.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$7K
- National Marrow Donor Program$5K
- Pfizer$3K
- Jazz Pharmaceuticals Inc.$2K
- Gilead$392
- Autolus Inc$216
- plus $434 from 4 others
Across 105 payments — averaging $5213.52 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$203K
- AbbVie$122K
- National Marrow Donor Program$64K
- Janssen Scientific Affairs, LLC$48K
- Astellas Pharma Global Development$45K
- Sanofi US Services Inc.$37K
- plus $27K from 4 others
What the payments were for
- Consulting fees$7,08539%
- Speaking & faculty fees$2,70015%
- Travel & lodging$5,48631%
- Food & beverage$2,64015%
- Gifts$690%
- Entertainment$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 5 | $7,366 |
| National Marrow Donor Program | 17 | $4,698 |
| Pfizer | 1 | $2,700 |
| Jazz Pharmaceuticals Inc. | 17 | $2,180 |
| Gilead | 3 | $392 |
| Autolus Inc | 2 | $216 |
| Novartis | 2 | $174 |
| Incyte Corporation | 1 | $122 |
| Sanofi-aventis U.S. LLC | 2 | $108 |
| Bristol Myers Squibb | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few transplant hepatology providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JakafiRuxolitinib Phosphate | 15 | $336,509 |
| Acyclovir | 25 | $311 |
| Penicillin V Potassium | 15 | $238 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 24 | $138 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Incyte CorporationJakafi | $122 | $336,50915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few transplant hepatology providers in North Carolinaon file to place this against a meaningful peer group, so we don't.
Other transplant hepatology in Winston Salem
- Zachariah McIverWinston Salem$263
- Mark RussoGreensboro$113K
- Andrew DelemosCharlotte$44K
- Neil ShahChapel Hill$29K
- Natasha AdlakhaHuntersville$1K
- Sasha Deutsch-LinkChapel Hill$1K
- Paul SchmeltzerCharlotte$497
- Rafael OrnelasDurham$401
- Beth FloydDurham$45
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.